McClarren Financial Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-731
| Closed | -$161K | – | 75 |
|
|
2025
Q1 | $161K | Sell |
731
-39
| -5% | -$8.59K | 0.11% | 79 |
|
|
2024
Q4 | $137K | Buy |
770
+63
| +9% | +$11.2K | 0.38% | 44 |
|
|
2024
Q3 | $71 | Buy |
707
+364
| +106% | +$37 | 0.01% | 108 |
|
|
2024
Q2 | $114K | Sell |
343
-327
| -49% | -$109K | 0.08% | 102 |
|
|
2024
Q1 | $122K | Buy |
670
+1
| +0.1% | +$182 | 0.09% | 98 |
|
|
2023
Q4 | $104K | Buy |
669
+4
| +0.6% | +$622 | 0.08% | 104 |
|
|
2023
Q3 | $99K | Buy |
665
+3
| +0.5% | +$447 | 0.09% | 100 |
|
|
2023
Q2 | $89K | Buy |
662
+3
| +0.5% | +$403 | 0.07% | 113 |
|
|
2023
Q1 | $104K | Buy |
659
+2
| +0.3% | +$316 | 0.09% | 98 |
|
|
2022
Q4 | $106K | Hold |
657
| – | – | 0.1% | 98 |
|
|
2022
Q3 | $88K | Buy |
+657
| New | +$88K | 0.09% | 96 |
|
|
2022
Q2 | – | Sell |
-357
| Closed | -$57K | – | 34 |
|
|
2022
Q1 | $57K | Hold |
357
| – | – | 0.04% | 116 |
|
|
2021
Q4 | $49K | Hold |
357
| – | – | 0.03% | 140 |
|
|
2021
Q3 | $38K | Hold |
357
| – | – | 0.03% | 133 |
|
|
2021
Q2 | $40K | Hold |
357
| – | – | 0.03% | 133 |
|
|
2021
Q1 | $39K | Hold |
357
| – | – | 0.03% | 124 |
|
|
2020
Q4 | $38K | Buy |
+357
| New | +$38K | 0.04% | 114 |
|